WARRANTCytokinetics Inc • March 11th, 2004 • Pharmaceutical preparations
Exhibit 4.5 LOAN AND SECURITY AGREEMENT THIS AGREEMENT (the "Agreement"), dated as of December 16, 1999 (the "Closing Date") is entered into by and between Cytokinetics, Incorporated, a Delaware corporation having a principal place of business at 280...Loan and Security Agreement • January 27th, 2004 • Cytokinetics Inc • Illinois
Exhibit 10.6 FIRST AMENDMENT TO LEASE THIS FIRST AMENDMENT TO LEASE ("Amendment"), dated (for reference purposes) as of April 13, 1998, is entered into by BRITANNIA POINTE GRAND LIMITED PARTNERSHIP, a Delaware limited partnership ("Landlord") and...Lease • January 27th, 2004 • Cytokinetics Inc
WARRANTCytokinetics Inc • March 11th, 2004 • Pharmaceutical preparations • California
Exhibit 1.1 CYTOKINETICS, INCORPORATED COMMON STOCK, $0.001 PAR VALUE UNDERWRITING AGREEMENTUnderwriting Agreement • March 11th, 2004 • Cytokinetics Inc • Pharmaceutical preparations • New York
RECITALSCommon Stock Purchase Agreement • March 11th, 2004 • Cytokinetics Inc • Pharmaceutical preparations • California
WARRANTCytokinetics Inc • March 11th, 2004 • Pharmaceutical preparations
Exhibit 10.10 SECOND AMENDMENT TO LEASE THIS SECOND AMENDMENT TO LEASE ("Second Amendment"), dated (for reference purposes) as of July 11, 1999, is entered into by BRITANNIA POINTE GRAND LIMITED PARTNERSHIP, a Delaware limited partnership...Lease • January 27th, 2004 • Cytokinetics Inc
EXHIBIT 4.4 Amendment No. One to Loan and Security Agreement This Amendment Agreement No. One ("Amendment") to the Loan and Security Agreement dated as of September 25, 1998 is entered into this 1st day of February, 1999 by and between Cytokinetics,...Loan and Security Agreement • March 11th, 2004 • Cytokinetics Inc • Pharmaceutical preparations
Cytokinetics, Incorporated, Issuer AND U.S. Bank National Association, Trustee INDENTURE Dated as of November 13, 2019 Debt SecuritiesIndenture • November 13th, 2019 • Cytokinetics Inc • Pharmaceutical preparations • New York
INDENTURE, dated as of November 13, 2019, among CYTOKINETICS, INCORPORATED, a Delaware corporation (the “Company”), and U.S. BANK NATIONAL ASSOCIATION, as trustee (the “Trustee”):
CYTOKINETICS, INCORPORATED AND _____________, AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF __________ CYTOKINETICS, INCORPORATED FORM OF PREFERRED STOCK WARRANT AGREEMENTWarrant Agreement • November 18th, 2022 • Cytokinetics Inc • Pharmaceutical preparations • New York
THIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between CYTOKINETICS, INCORPORATED, a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
Exhibit 4.5 THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AS AMENDED, OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT...Cytokinetics Inc • March 11th, 2004 • Pharmaceutical preparations • Illinois
Cytokinetics, Incorporated Shares of Common Stock (par value $0.001 per share) Amended and Restated Controlled Equity OfferingSM Sales AgreementSales Agreement • March 1st, 2023 • Cytokinetics Inc • Pharmaceutical preparations
Cytokinetics, Incorporated, a Delaware corporation (the “Company”), confirms its amended and restated agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
RECITALSModification Agreement • January 27th, 2004 • Cytokinetics Inc
CYTOKINETICS, INCORPORATED AND , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [ ], 20Common Stock Warrant Agreement • December 16th, 2016 • Cytokinetics Inc • Pharmaceutical preparations • New York
COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between CYTOKINETICS, INCORPORATED, a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
CYTOKINETICS, INCORPORATED AND _____________, AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF __________ CYTOKINETICS, INCORPORATED FORM OF DEBT SECURITIES WARRANT AGREEMENTWarrant Agreement • November 18th, 2022 • Cytokinetics Inc • Pharmaceutical preparations • New York
THIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [•], between CYTOKINETICS, INCORPORATED, a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
5,260,000 Shares of Common Stock CYTOKINETICS, INCORPORATED UNDERWRITING AGREEMENTUnderwriting Agreement • May 9th, 2017 • Cytokinetics Inc • Pharmaceutical preparations • New York
RECITALSInvestors' Rights Agreement • January 27th, 2004 • Cytokinetics Inc • California
CYTOKINETICS, INCORPORATED AND , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF [ ], 20Preferred Stock Warrant Agreement • December 16th, 2016 • Cytokinetics Inc • Pharmaceutical preparations • New York
PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between CYTOKINETICS, INCORPORATED, a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
1. PREMISES ......................................... 1 1.1 Lease of Premises ........................... 1 1.2 Landlord's Reserved Rights .................. 2 1.3 First Refusal Right ......................... 2 2. TERM...Cytokinetics Inc • January 27th, 2004 • California
BACKGROUNDCollaboration Agreement • January 27th, 2004 • Cytokinetics Inc • California
BETWEENExclusive License Agreement • January 27th, 2004 • Cytokinetics Inc • California
RECITALSExecutive Employment Agreement • November 12th, 2004 • Cytokinetics Inc • Pharmaceutical preparations • California
Exhibit 4.3 LOAN AND SECURITY AGREEMENT THIS AGREEMENT (the "Agreement"), dated as of September 25, 1998 (the "Closing Date") is entered into by and between Cytokinetics, Incorporated, a Delaware corporation having a principal place of business at 280...Loan and Security Agreement • March 11th, 2004 • Cytokinetics Inc • Pharmaceutical preparations • Illinois
CYTOKINETICS, INCORPORATED and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [●], 20Debt Securities Warrant Agreement • November 3rd, 2017 • Cytokinetics Inc • Pharmaceutical preparations • New York
This DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between CYTOKINETICS, INCORPORATED, a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
RECITALSCollaboration and License Agreement • April 29th, 2004 • Cytokinetics Inc • Pharmaceutical preparations • New York
WARRANTCytokinetics Inc • January 27th, 2004
CYTOKINETICS, INCORPORATED AND _____________, AS TRUSTEE FORM OF INDENTURE DATED AS OF __________ Debt SecuritiesCytokinetics Inc • November 18th, 2022 • Pharmaceutical preparations • New York
THIS INDENTURE, dated as of [•], between CYTOKINETICS, INCORPORATED, a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
Exhibit 4.6 LOAN AND SECURITY AGREEMENT THIS AGREEMENT (the "Agreement"), dated as of December 16, 1999 (the "Closing Date") is entered into by and between Cytokinetics, Incorporated, a Delaware corporation having a principal place of business at 280...Loan and Security Agreement • March 11th, 2004 • Cytokinetics Inc • Pharmaceutical preparations • Illinois
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 15th, 2007 • Cytokinetics Inc • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of October 15, 2007, is by and between CYTOKINETICS, INCORPORATED (the “Company”) and KINGSBRIDGE CAPITAL LIMITED (the “Investor”).
ContractCytokinetics Inc • March 3rd, 2016 • Pharmaceutical preparations • California
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
Exhibit 10.27 CYTOKINETICS, INCORPORATED AMENDMENT NO. 1 TO SERIES D PREFERRED STOCK PURCHASE AGREEMENT THIS AMENDMENT is made this 2nd day of April, 2003, between Cytokinetics, Incorporated, a Delaware corporation (the "Company"), Glaxo Wellcome...Series D Preferred Stock Purchase Agreement • January 27th, 2004 • Cytokinetics Inc • California
ContractCytokinetics Inc • August 9th, 2019 • Pharmaceutical preparations • California
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
ContractCytokinetics Inc • August 9th, 2019 • Pharmaceutical preparations • California
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
COMMON STOCK PURCHASE AGREEMENT by and between KINGSBRIDGE CAPITAL LIMITED and CYTOKINETICS, INCORPORATED dated as of October 15, 2007Common Stock Purchase Agreement • October 15th, 2007 • Cytokinetics Inc • Pharmaceutical preparations • New York
This COMMON STOCK PURCHASE AGREEMENT (the “Agreement”) is entered into as of the 15th day of October, 2007, by and between Kingsbridge Capital Limited, an entity organized and existing under the laws of the British Virgin Islands, whose registered address is Palm Grove House, 2nd Floor, Road Town, Tortola, British Virgin Islands (the “Investor”) and Cytokinetics, Incorporated, a corporation organized and existing under the laws of the State of Delaware (the “Company”).
